These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1996879)

  • 1. Major differences in the dynamics of primary and secondary progressive multiple sclerosis.
    Thompson AJ; Kermode AG; Wicks D; MacManus DG; Kendall BE; Kingsley DP; McDonald WI
    Ann Neurol; 1991 Jan; 29(1):53-62. PubMed ID: 1996879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.
    Smith ME; Stone LA; Albert PS; Frank JA; Martin R; Armstrong M; Maloni H; McFarlin DE; McFarland HF
    Ann Neurol; 1993 May; 33(5):480-9. PubMed ID: 8498825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis.
    Katz D; Taubenberger JK; Cannella B; McFarlin DE; Raine CS; McFarland HF
    Ann Neurol; 1993 Nov; 34(5):661-9. PubMed ID: 8239560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in multiple sclerosis: an overview.
    Colosimo M; Amatruda A; Cioffi RP
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):113-23. PubMed ID: 1345732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis.
    Losseff NA; Kingsley DP; McDonald WI; Miller DH; Thompson AJ
    Mult Scler; 1996 Feb; 1(4):218-22. PubMed ID: 9345438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
    Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C
    J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical usefulness of MRI in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase].
    Nomura M; Suzumura A; Anno H; Miyata E; Koga S; Yamamoto H
    Rinsho Shinkeigaku; 1995 Mar; 35(3):225-30. PubMed ID: 7614741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages].
    Rüttinger H; Hermes M
    Nervenarzt; 1990 Jun; 61(6):356-60. PubMed ID: 2377261
    [No Abstract]   [Full Text] [Related]  

  • 10. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features.
    Koopmans RA; Li DK; Grochowski E; Cutler PJ; Paty DW
    Ann Neurol; 1989 Jan; 25(1):74-81. PubMed ID: 2913931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Magnetic resonance imaging of disseminated sclerosis].
    Christiansen AP; Wanscher B; Larsson HB; Henriksen O
    Ugeskr Laeger; 1994 Oct; 156(43):6348-52. PubMed ID: 7810007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mitoxantrone on MRI in progressive MS: results of the MIMS trial.
    Krapf H; Morrissey SP; Zenker O; Zwingers T; Gonsette R; Hartung HP;
    Neurology; 2005 Sep; 65(5):690-5. PubMed ID: 16157900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of synovial lesions by MRI using gadolinium-DTPA (Gd-DTPA) in patient with early phase of rheumatoid arthritis].
    Takano K
    Ryumachi; 1993 Feb; 33(1):3-11. PubMed ID: 8493583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
    Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J
    Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
    Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
    Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.
    Bagnato F; Jeffries N; Richert ND; Stone RD; Ohayon JM; McFarland HF; Frank JA
    Brain; 2003 Aug; 126(Pt 8):1782-9. PubMed ID: 12821527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.
    Tortorella C; Bellacosa A; Paolicelli D; Fuiani A; Di Monte E; Simone IL; Giaquinto P; Livrea P; Trojano M
    J Neurol Sci; 2005 Dec; 239(1):95-9. PubMed ID: 16209877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
    Bastianello S; Pozzilli C; Bernardi S; Bozzao L; Fantozzi LM; Buttinelli C; Fieschi C
    Neurology; 1990 Apr; 40(4):591-5. PubMed ID: 2320230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI dynamics of brain and spinal cord in progressive multiple sclerosis.
    Kidd D; Thorpe JW; Kendall BE; Barker GJ; Miller DH; McDonald WI; Thompson AJ
    J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):15-9. PubMed ID: 8558143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
    Miller DH; Rudge P; Johnson G; Kendall BE; Macmanus DG; Moseley IF; Barnes D; McDonald WI
    Brain; 1988 Aug; 111 ( Pt 4)():927-39. PubMed ID: 3401689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.